Esteban Santos - Amgen Insider

AMGN -- USA Stock  

USD 186.19  0.20  0.11%

Executive Vice President Operations

Mr. Esteban Santos is Executive Vice President, Operations of the Company. Mr. Santos became Executive Vice President, Operations in July 2016. Mr. Santos joined the Company in 2007 as Executive Director, Manufacturing Technologies. From October 2008 to May 2013, Mr. Santos held a number of Vice President roles at the Company in engineering, manufacturing, site operations and drug product. From May 2013 to July 2016, Mr. Santos was Senior Vice President, Manufacturing. Prior to joining the Company, Mr. Santos served as Site General Manager for JJs Cordis operation in Puerto Rico. Prior to JJ, Mr. Santos held several management positions in GEs industrial and transportation businesses.
Age: 48  President Since 2016      

Esteban Santos Latest Insider Activity

Esteban Santos over a month ago via Macroaxis 
Amgen exotic insider transaction detected
Esteban Santos over three months ago via Macroaxis 
Amgen exotic insider transaction detected
Esteban Santos over six months ago via Macroaxis 
Amgen exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 8.84 % which means that it generated profit of $8.84 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 9.59 % meaning that it created $9.59 on every $100 dollars invested by stockholders.
The company currently holds 35.54 B in liabilities with Debt to Equity (D/E) ratio of 227.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen has Current Ratio of 3.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Charles FoltzAbbott Laboratories
Thomas FrinziAbbott Laboratories
Leigh PuseyEli Lilly and Company
Barton PetersonEli Lilly and Company
Murdo GordonBristol Myers Squibb Company
Aarti ShahEli Lilly and Company
Roger PerlmutterMerck Co
Sanat ChattopadhyayMerck Co
Deepak NathAbbott Laboratories
Paul BiondiBristol Myers Squibb Company
Michael RosenblattMerck Co
Susan MahonyEli Lilly and Company
Terrance CoughlinEndo International plc
David RicksEli Lilly and Company
Ann JudgeBristol Myers Squibb Company
Maria CroweEli Lilly and Company
Joseph CaldarellaBristol Myers Squibb Company
Francis CussBristol Myers Squibb Company
Antonio PeraEndo International plc
Philippe SchaisonAllergan plc
Matthew MalettaEndo International plc

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people.Amgen (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Amgen Leadership Team

Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance Indicators

Did you try this?

Run Transaction History Now

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Transaction History

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Amgen and IQVIA Holdings. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.